May 03, 2017
BIOPHYTIS confirms that Sarconeos modulates the Renin-Angiotensin System and activates muscular metabolism in the SARA-PK clinical trial. Read the Press Release
BIOPHYTIS confirms that Sarconeos modulates the Renin-Angiotensin System and activates muscular metabolism in the SARA-PK clinical trial. Read the Press Release
Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT. Read the Press Release
Biophytis opens the first clinical centers in Europe and starts the recruitment of sarcopenic patients for SARA-OBS study. Read the Press Release
Biophytis to present four scientific studies at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Barcelona. Read the Press Release
Les résultats de l’étude SARA-PK confirment le bon profil pharmacocinétique de Sarconeos chez le sujet âgé. Lire le communiqué de presse
Biophytis relocates to Pierre and Marie Curie University (UPMC) campus and solidifies creation of leading translational platform for age-related disease. Read the Press Release
BIOPHYTIS to participate to the JP Morgan Annual Healthcare Conference in San Francisco, January 9-12th 2017. Read the Press Release.
Biophytis presents preliminary clinical data of SARA-PK, and new preclinical data of Sarconeos for treating sarcopenia. Read the Press Release
BIOPHYTIS Announces Successful Completion of SARA-PK Clinical Study for Sarconeos in Sarcopenia Confirming Safety Profile. Read the Press Release